Literature DB >> 21391983

Spinal neuronal NOS activation mediates sigma-1 receptor-induced mechanical and thermal hypersensitivity in mice: involvement of PKC-dependent GluN1 phosphorylation.

Dae-Hyun Roh1, Sheu-Ran Choi, Seo-Yeon Yoon, Suk-Yun Kang, Ji-Young Moon, Soon-Gu Kwon, Ho-Jae Han, Alvin J Beitz, Jang-Hern Lee.   

Abstract

BACKGROUND AND PURPOSE We recently demonstrated that activation of the spinal sigma-1 receptor induces mechanical and thermal hypersensitivity via calcium-dependent second messenger cascades and phosphorylation of the spinal NMDA receptor GluN1 subunit (pGluN1). Here we examined the role of NO in this process, as it plays a critical role in PKC-mediated calcium signalling and the potentiation of NMDA receptor function. EXPERIMENTAL APPROACH The effects of intrathecal (i.t.) pretreatment with nNOS inhibitors on PRE084 (sigma-1 receptor agonist)-induced pain were assessed in mice by use of mechanical allodynia and thermal hyperalgesia tests. Western blot analysis, immunoprecipitation and immunohistochemical techniques were used to determine effects of these treatments on spinal pGluN1-immunoreactive (ir) cells, whether PRE084 induces a time-dependent modification of nNOS activity in the dorsal horn, and if any changes in nNOS activity can be blocked by sigma-1 receptor, calcineurin or soluble guanylyl cyclase (sGC) inhibitors. KEY RESULTS PRE084, injected i.t., induced mechanical and thermal hypersensitivity, and increased the number of PKC- and PKA-dependent pGluN1-ir cells in spinal cord. This PRE084-induced hypersensitivity and increase in PKC-dependent pGluN1 expression were blocked by pretreatment with N(G) -nitro-L-arginine methyl ester (L-NAME) or 7-nitroindazole (7-NI). PRE084 also time-dependently decreased the ratio of phosphorylated nNOS (pnNOS) to nNOS expression and the number of spinal pnNOS-ir cells. This decrease in pnNOS was prevented by BD1047, a sigma-1 receptor antagonist and cyclosporin A, a calcineurin inhibitor, but not by a sGC inhibitor. CONCLUSIONS AND IMPLICATIONS Spinal sigma-1 receptor-induced sensitization is mediated by an increase in nNOS activity, which is associated with an NO-induced increase in PKC-dependent pGluN1 expression.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391983      PMCID: PMC3166697          DOI: 10.1111/j.1476-5381.2011.01316.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  Nitric oxide-sensitive guanylyl cyclase: structure and regulation.

Authors:  Doris Koesling; Michael Russwurm; Evanthia Mergia; Florian Mullershausen; Andreas Friebe
Journal:  Neurochem Int       Date:  2004-11       Impact factor: 3.921

2.  Phosphorylation of neuronal nitric oxide synthase at Ser847 in the nucleus intermediolateralis after spinal cord injury in mice.

Authors:  K Osuka; Y Watanabe; N Usuda; K Atsuzawa; C Aoshima; K Yamauchi; M Takayasu; J Yoshida
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

3.  Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice.

Authors:  Hyun-Woo Kim; Young-Bae Kwon; Dae-Hyun Roh; Seo-Yeon Yoon; Ho-Jae Han; Kee-Won Kim; Alvin J Beitz; Jang-Hern Lee
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

4.  Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains.

Authors:  J E Brenman; D S Chao; S H Gee; A W McGee; S E Craven; D R Santillano; Z Wu; F Huang; H Xia; M F Peters; S C Froehner; D S Bredt
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

Review 5.  Protein S-nitrosylation: purview and parameters.

Authors:  Douglas T Hess; Akio Matsumoto; Sung-Oog Kim; Harvey E Marshall; Jonathan S Stamler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

Review 6.  PKC delta and epsilon in drug targeting and therapeutics.

Authors:  Tomo Yonezawa; Riho Kurata; Minoru Kimura; Hidetoshi Inoko
Journal:  Recent Pat DNA Gene Seq       Date:  2009

Review 7.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

8.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

9.  Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury.

Authors:  Beatriz de la Puente; Xavier Nadal; Enrique Portillo-Salido; Ricard Sánchez-Arroyos; Sergio Ovalle; Gabriel Palacios; Asunción Muro; Luz Romero; José Manuel Entrena; José Manuel Baeyens; José Antonio López-García; Rafael Maldonado; Daniel Zamanillo; José Miguel Vela
Journal:  Pain       Date:  2009-06-07       Impact factor: 6.961

Review 10.  Concepts of neural nitric oxide-mediated transmission.

Authors:  John Garthwaite
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

View more
  20 in total

1.  σ1 receptors activate astrocytes via p38 MAPK phosphorylation leading to the development of mechanical allodynia in a mouse model of neuropathic pain.

Authors:  J Y Moon; D H Roh; S Y Yoon; S R Choi; S G Kwon; H S Choi; S Y Kang; H J Han; A J Beitz; S B Oh; J H Lee
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 2.  Sigma-1 receptor and inflammatory pain.

Authors:  Georgia Gris; Enrique José Cobos; Daniel Zamanillo; Enrique Portillo-Salido
Journal:  Inflamm Res       Date:  2015-04-23       Impact factor: 4.575

3.  Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors.

Authors:  M A Tejada; A Montilla-García; C Sánchez-Fernández; J M Entrena; G Perazzoli; J M Baeyens; E J Cobos
Journal:  Psychopharmacology (Berl)       Date:  2014-03-18       Impact factor: 4.530

4.  Nitric oxide modulated the expression of DREAM/calsenilin/KChIP3 in inflammatory pain of rats.

Authors:  Hong-Bo Jin; Yong-Liang Yang; Ying-Li Song; Yong-Bin Yang; Yu-Rong Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

5.  The antagonistic effect of the sigma 1 receptor ligand (+)-MR200 on persistent pain induced by inflammation.

Authors:  Carmela Parenti; Agostino Marrazzo; Giuseppina Aricò; Rosalba Parenti; Lorella Pasquinucci; Simone Ronsisvalle; Giuseppe Ronsisvalle; Giovanna Maria Scoto
Journal:  Inflamm Res       Date:  2013-12-08       Impact factor: 4.575

6.  Effects of a selective sigma 1 antagonist compound on inflammatory pain.

Authors:  Carmela Parenti; Agostino Marrazzo; Giuseppina Aricò; Giuseppina Cantarella; Orazio Prezzavento; Simone Ronsisvalle; Giovanna Maria Scoto; Giuseppe Ronsisvalle
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

7.  Ghrelin receptor activity amplifies hippocampal N-methyl-d-aspartate receptor-mediated postsynaptic currents and increases phosphorylation of the GluN1 subunit at Ser896 and Ser897.

Authors:  Brandon G Muniz; Masako Isokawa
Journal:  Eur J Neurosci       Date:  2015-11-17       Impact factor: 3.386

Review 8.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

9.  Sigma-1 receptor expression in sensory neurons and the effect of painful peripheral nerve injury.

Authors:  Madhavi L Bangaru; Dorothee Weihrauch; Qing-Bo Tang; Vasiliki Zoga; Quinn Hogan; Hsiang-en Wu
Journal:  Mol Pain       Date:  2013-09-10       Impact factor: 3.395

10.  Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system.

Authors:  Marta Valenza; Angelo Blasio; Alyssa DiLeo; Pietro Cottone; Valentina Sabino
Journal:  Pharmacol Biochem Behav       Date:  2020-03-20       Impact factor: 3.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.